Late-stage age-related macular degeneration (AMD) is an advanced form of AMD, where damage to the central vision area of the retina, the macula, occurs. Late-stage AMD is the leading cause of irreversible vision loss for people over 60 years old.
A clinical study to test the safety and effectiveness of an implantable miniature telescope (IMT) in patients with central vision impairment associated with late- stage age-related macular degeneration (AMD).
The purpose of this device is to magnify what a patient is seeing and project this image onto the retina, enabling the patient to recognize and identify objects that could not otherwise be seen.
We’re conducting a clinical study to evaluate an implantable miniature telescope (IMT) device for central vision loss associated with late-stage age-related macular degeneration (AMD).
Age-Related Macular Degeneration
5 visits over 12-15 months plus vision rehabilitation
Eligible patients will be compensated for each study visit.
Loma Linda, CA
We are adding new locations for this study regularly. Please fill out the form below to learn more.
If you are interested in referring late-stage AMD patients to the CONCERTO study:
Fill out the contact information section below for each potential patient. The patient will be contacted for a pre-screening discussion within 72 hours.
Have the patient/caregiver call 1-866-393-3767 to discuss eligibility, potential participation, and to answer any questions they may have.
If you want to learn more, or to see if you or a loved one qualifies for the CONCERTO study:
Fill out the contact information below. You will be contacted for a pre-screening discussion within 72 hours.
Call 1-866-393-3767 to discuss eligibility, potential participation, and to answer any questions you may have.